Table 1 Demographic information for cases used in this study. PMI: post-mortem interval. *Cases used for histological analysis. ^#Cases with co-occurring ALS.

1​

C9orf72​

65​

F​

5​

Bronchopneumonia​

A​

2​

C9orf72​

49​

F​

26​

Aspiration pneumonia​

B​

3​

C9orf72​

66​

M​

9​

Cardiorespiratory failure​

B​

4​

C9orf72​

81​

F​

14​

Cardiorespiratory arrest​

B​

5^#​

C9orf72​

68​

F​

9​

Cardiorespiratory failure​

A​

6​

C9orf72​

75​

F​

46​

Cardiorespiratory failure​

A​

7​^#

C9orf72​

70​

M​

15​

Cardiorespiratory failure​

A​

8*​

C9orf72​

61​

M​

39​

Aspiration pneumonia​

A​

9*​

C9orf72​

69​

F​

24​

Cardiorespiratory failure​

B​

10*​

C9orf72​

67​

F​

22​

Cardiorespiratory failure​

A​

11*​

C9orf72​

83​

M​

13​

Uraemia, bronchopneumonia​

A​

12​

GRN (c.90_91insCTGS)

77​

M​

48​

Aspiration pneumonia​

A​

13*​

GRN​ ​(c.90_91insCTGS)

54​

F​

26​

Aspiration pneumonia​

A​

14*​

GRN​ (c.898 C > T)

54​

F​

21​

Cardiorespiratory failure​

A​

15​

GRN​ (c.898 C > T)

61​

M​

17​

Cardiorespiratory failure​

A​

16​

GRN​ (c.87dup)

64​

M​

13​

Cardiorespiratory failure​

A​

17*​

GRN​ (c.918 C > A)

68​

F​

29​

Cardiorespiratory failure​

A​

18*​

Control​

69​

M​

16​

Cardiac​

-​

19*​

Control​

60​

M​

25​

Infection​

-​

20*​

Control​

71​

F​

16​

Cancer​

-​

21​

Control​

66​

M​

23​

Cardiac​

-​

22​

Control​

66​

M​

63​

Cardiac​

-​

23​

Control​

69​

F​

39​

Cardiac/ Respiratory​

-​

24​

Control​

73​

M​

9​

Cancer​

-​

25​

Control​

51​

F​

41​

Alcohol toxicity​

-​

26​

Control​

84​

M​

36​

Severe pulmonary hypertension​

-​

27*​

Control​

80​

F​

29​

Cardiorespiratory failure​

-​

28*​

Control​

84​

F​

16​

Endocarditis​

-​